159 related articles for article (PubMed ID: 22431775)
1. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions.
de Vries E; Micallef R; Brewster DH; Gibbs JH; Flohil SC; Saksela O; Sankila R; Forrest AD; Trakatelli M; Coebergh JW; Proby CM;
Arch Dermatol; 2012 Mar; 148(3):347-54. PubMed ID: 22431775
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions.
Flohil SC; Proby CM; Forrest AD; van Tiel S; Saksela O; Pitkänen S; Ahti T; Micallef R; de Vries E;
Br J Dermatol; 2012 Aug; 167 Suppl 2():22-8. PubMed ID: 22881584
[TBL] [Abstract][Full Text] [Related]
3. A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence.
Schreuder K; Hollestein L; Nijsten TEC; Wakkee M; Louwman MWJ
Br J Dermatol; 2022 Mar; 186(3):476-484. PubMed ID: 34726263
[TBL] [Abstract][Full Text] [Related]
4. The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study.
Kappelin J; Ahnlide I; Ingvar Å; Nielsen K
Acta Derm Venereol; 2024 May; 104():adv40112. PubMed ID: 38803206
[TBL] [Abstract][Full Text] [Related]
5. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
6. Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice.
Flohil SC; van Tiel S; Koljenović S; Jaanen-van der Sanden G; Overbeek LI; de Vries E; Nijsten T
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):907-11. PubMed ID: 22211725
[TBL] [Abstract][Full Text] [Related]
7. [Basal cell carcinoma: often more than one].
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Ned Tijdschr Geneeskd; 2011; 155(47):A4110. PubMed ID: 22129810
[TBL] [Abstract][Full Text] [Related]
8. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
10. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
Flohil SC; de Vries E; Neumann HA; Coebergh JW; Nijsten T
Acta Derm Venereol; 2011 Jan; 91(1):24-30. PubMed ID: 21264452
[TBL] [Abstract][Full Text] [Related]
11. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area.
Bielsa I; Soria X; Esteve M; Ferrándiz C;
Br J Dermatol; 2009 Dec; 161(6):1341-6. PubMed ID: 19796178
[TBL] [Abstract][Full Text] [Related]
12. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
[TBL] [Abstract][Full Text] [Related]
14. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of basal cell carcinoma in Lithuania, 1996-2010.
Jurciukonyte R; Vincerzevskiene I; Krilaviciute A; Bylaite M; Smailyte G
Br J Dermatol; 2013 Nov; 169(5):1100-5. PubMed ID: 23795568
[TBL] [Abstract][Full Text] [Related]
16. Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population.
Ray GT; Kulldorff M; Asgari MM
JAMA Dermatol; 2016 Nov; 152(11):1218-1224. PubMed ID: 27439152
[TBL] [Abstract][Full Text] [Related]
17. Incidence of eyelid basal cell carcinoma in England: 2000-2010.
Saleh GM; Desai P; Collin JR; Ives A; Jones T; Hussain B
Br J Ophthalmol; 2017 Feb; 101(2):209-212. PubMed ID: 27130914
[TBL] [Abstract][Full Text] [Related]
18. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.
Chuang TY; Reizner GT; Elpern DJ; Stone JL; Farmer ER
J Am Acad Dermatol; 1995 Sep; 33(3):422-6. PubMed ID: 7657865
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]